- Home
- CRON vs VIR Comparison
CRON vs VIR Comparison
Compare CRON & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRON | VIR |
|---|---|---|
| Founded | N/A | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.5B |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CRON | VIR |
|---|---|---|
| Price | $3.23 | $11.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | 757.9K | ★ 1.9M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $146,587,000.00 | $68,556,000.00 |
| Revenue This Year | $46.73 | $257.66 |
| Revenue Next Year | $23.43 | N/A |
| P/E Ratio | $26.83 | ★ N/A |
| Revenue Growth | ★ 24.63 | N/A |
| 52 Week Low | $2.28 | $4.82 |
| 52 Week High | $3.61 | $11.94 |
Technical Indicators
Market Signals| Indicator | CRON | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 59.75 |
| Support Level | $2.65 | $8.43 |
| Resistance Level | $3.28 | $11.77 |
| Average True Range (ATR) | 0.09 | 0.65 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 23.03 | 84.43 |
Price Performance
Historical ComparisonAbout CRON Cronos Group Inc.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.